Crystalloids, colloids, blood, blood products and blood substitutes

References 

1. Stewart PA. How to understand acid–base a quantitative acid–base primer for biology and medicine. New York: Elsevier; 1981;
2. http://www.ics.ac.uk/downloads/2008112340_GIFTASUP%20FINAL_31-10-08.pdf (accessed 11th May 2009).
3. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. BJA. 2008;101:141–150
4. White SA, Goldhill DR. Is Hartmann's the solution?. Anaesthesia. 1997;52:422–427
   • MEDLINE
5. Thomas DJB, Alberti KGMM. Hyperglycaemic effects of Hartmann's solution during surgery in patients with maturity onset diabetes. BJA. 1978;50:185–187
6. Bunn F, Roberts IG, Tasker R, Trivedi D. Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004;Art. No.: CD002045
7. Angele MK, Schneider CP, Chaudry I. Bench-to-bedside review: latest results in haemorrhagic shock. Crit Care. 2008;12:218
   • CrossRef
8. Downar J, Lapinsky S. Pro/con debate: should synthetic colloids be used in patients with septic shock?. Crit Care. 2009;13:203
   • CrossRef
9. UK blood safety and quality regulations 2005. Statutory Instrument No. 50. Crown Copyright 2005. <http://www.opsi.gov.uk/si/si2005/20050050.htm> (accessed 11 Dec 2009).
10. Stroncek D, Rebulla P. Transfusion medicine 2, platelet transfusions. Lancet. 2007;370:427–438
    • Abstract
    • Full Text
    • Full-Text PDF (338 KB)
    • CrossRef
11. Key N, Negrier C. Transfusion medicine 3, coagulation factor concentrates: past, present, and future. Lancet. 2007;370:439–448
    • Abstract
    • Full Text
    • Full-Text PDF (156 KB)
    • CrossRef
12. In:  McLelland DBL editors. Handbook of Transfusion Medicine. 4th edn. The Stationery Office; 2007;
13. Natanson C, Kern SJ, Lurie P, et al. Cell-free haemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA. 2008;299:2304–2312
    • CrossRef